Hello! You are part of a community of millions who seek out Democracy Now! each month for ad-free daily news you can trust. Maybe you come for our daily headlines. Maybe you come for our in-depth stories that expose corporate and government abuses of power and lift up the voices of ordinary people working to make change in extraordinary times. We produce all of this news at a fraction of the budget of a commercial news operation. We do this without ads, government funding or corporate sponsorship. How? This model of news depends on support from viewers and listeners like you. Today, less than 1% of our visitors support Democracy Now! with a donation each year. If even 3% of our website visitors donated just $10 per month, we could cover our basic operating expenses for a year. Pretty amazing right? If you visit us daily or weekly or even just once a month, now is a great time to make a monthly contribution.

Your Donation: $
Tuesday, October 23, 2001 FULL SHOW | HEADLINES | NEXT: A Case in Domestic Terrorism: A Look at the Violence...
2001-10-23

Cipro: The Battle Over Bayer

DONATE →
This is viewer supported news

Today we’re going to look at the pharmaceutical giant Bayer, the maker of Cipro.

Bayer has long been a controversial company, beginning with its roots in the German company IG Farben, which workedhand in hand with the Nazis.

It has been sued by holocaust survivors for its role in forced labor, medical experiments and other crimes.

Its been sued by people with Hemophilia who contracted AIDS though tainted blood transfusions.

And it has been targeted by AIDS activists around the world for fighting against cheap AIDS drugs for poorercountries.

Cipro, the antibiotic that many say can help treat anthrax, is ten times as expensive as generic equivalents. That’swhat made Senator Charles Schumer call for the Bush Administration to break Bayer’s patent and produce genericequivalents of the drug.

The Bayer/Cipro controversy is a microcosm of the global conflict between public health and private profit, betweenthe needs of poor countries for cheap medicines and the desire of rich corporations to preserve their patents. Its aconflict that will come to head in a little over a week when the WTO hold’s a major ministerial meeting in Qatar,where poor countries will press the US to relax drug patents on life saving medicines.

Guests:

  • Sharon Anne Lynch, Health Gap global access project and ACT-UP New York.
  • James Love, Consumer Project on Technology.
  • Philipp Mimkes, Coordination Against BAYER-Dangers (CBG).

Related links:

Recent Shows More

Full News Hour

Stories


Creative Commons License The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.